Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis

Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee

Intest Res. 2021;19(3):323-331. Published online August 18, 2020
DOI: https://doi.org/10.5217/ir.2020.00039

Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis

Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee

Intestinal Research. 2021;19(3):323-331

Link1

Link2 Link3

Su1402 Short and Long Term Outcomes of Severe Ulcerative Colitis Patients Treated With Tacrolimus and Infliximab

Naoki Minami, Takuya Yoshino, Minoru Matsuura, Hiroshi Nakase

Gastroenterology. 2014;146(5):S-460

Link1 Link2

‘Infliximab-First’ vs ‘Colectomy-First’ Management in Acute Severe Ulcerative Colitis: Comparison of Long-Term Outcomes, Inpatient Costs, and Complication

Asiri Arachchi, Abhinav Vasudevan

Journal of the American College of Surgeons. 2018;227(4):e137

Link1 Link2 Link3

Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis

Stack, Long, Hawkey

Alimentary Pharmacology & Therapeutics. 1998;12(10):973-978

Link1 Link2 Link3

Comparison of Long-Term Outcomes of Infliximab and Adalimumab Therapy in Biologic-Naive Patients with Ulcerative Colitis

Muhammed Bahaddin Durak, Cem Şimşek, İlhami Yüksel

. 2023;

Link1 Link2

Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis

Kata Szemes, Alexandra Soós, Péter Hegyi, Nelli Farkas, Adrienn Erős, Bálint Erőss, Emese Mezősi, Zsolt Szakács, Katalin Márta, Patrícia Sarlós

Frontiers in Medicine. 2020;6:

Link1

Intensified Infliximab Rescue Therapy for Acute Severe Ulcerative Colitis does not Improve Long Term Colectomy-Free Survival

Alex Al Khoury, Che-yung Chao, Talat Bessissow, Jonathan Wyse, Achuthan Aruljothy

Gastroenterology. 2017;152(5):S399

Link1 Link2

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

A. KOHN, M. DAPERNO, A. ARMUZZI, M. CAPPELLO, L. BIANCONE, A. ORLANDO, A. VISCIDO, V. ANNESE, G. RIEGLER, G. MEUCCI, M. MARROLLO, R. SOSTEGNI, A. GASBARRINI, S. PERALTA, C. PRANTERA

Alimentary Pharmacology & Therapeutics. 2007;26(5):747-756

Link1 Link2

Mo1868 - Medium to Long Term Outcomes in Patients Receiving Accelerated Dose Infliximab Induction for Acute Severe Ulcerative Colitis (ASUC) in a Mulit-Centre Cohort

David J. Gibson, Jayne Doherty, Mairead McNally, Aine M. Keogh, Denise Keegan, Kathryn Byrne, Una Kennedy, Hugh E. Mulcahy, Susan McKiernan, Finbar MacCarthy, Laurence Egan, Garret Cullen, Juliette Sheridan, Subhasish Sengupta, Eoin Slattery, David Kevans, Glen A. Doherty

Gastroenterology. 2018;154(6):S-832

Link1 Link2

Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis

Niharika Nalagatla, Katherine Falloon, Gloria Tran, Nienke Z. Borren, Danny Avalos, Jay Luther, Francis Colizzo, John Garber, Hamed Khalili, Joanna Melia, Matthew Bohm, Ashwin N. Ananthakrishnan

Clinical Gastroenterology and Hepatology. 2019;17(3):502-509.e1

Link1 Link2